Welcome to our dedicated page for Option Care Health news (Ticker: OPCH), a resource for investors and traders seeking the latest updates and insights on Option Care Health stock.
News about Option Care Health, Inc. (OPCH) centers on its role as the nation’s largest independent provider of home and alternate site infusion services and on its regular financial and corporate updates. The company issues detailed quarterly earnings releases, often accompanied by Form 8-K filings, that cover net revenue, net income, earnings per share, and non-GAAP metrics such as Adjusted EBITDA, Adjusted net income and Adjusted diluted EPS.
Investors following OPCH news will see announcements of preliminary and final quarterly and full-year financial results, as well as updated financial guidance ranges for net revenue, Adjusted EBITDA and Adjusted diluted earnings per share. These releases typically include management commentary on performance, cash flow from operations, stock repurchase activity and capital structure developments.
Option Care Health also uses news releases to communicate capital allocation decisions, such as expansions of its share repurchase program authorization, and to describe amendments to its credit agreements that affect term loans and revolving credit facilities. SEC Form 8-K filings referenced in the news provide additional detail on these material definitive agreements and financial obligations.
Corporate governance and leadership changes are another recurring news theme. For example, the company has announced a Chief Financial Officer transition, outlining the incoming CFO’s background, compensation arrangements and the outgoing CFO’s advisory role. News items also highlight Option Care Health’s participation in major healthcare and finance conferences, including events hosted by J.P. Morgan, UBS, Jefferies, Deutsche Bank and Bank of America, with webcasts and presentation materials made available to investors.
In addition, Option Care Health appears in partner company releases, such as Quince Therapeutics’ announcements of a strategic relationship for specialty infusion therapy support. These items describe how Option Care Health’s national network of specialty pharmacies and ambulatory infusion suites may be used to administer specific infused therapies, particularly in rare disease indications. For ongoing coverage of these financial, strategic and operational developments, OPCH news on this page aggregates company press releases, partner announcements and related disclosures.
Option Care Health (NASDAQ: OPCH), the largest independent provider of home and alternate site infusion services in the U.S., will present at the Bank of America 2021 Health Care Conference on May 11, 2021, at 8:45 a.m. EDT. CEO John Rademacher and CFO Mike Shapiro are scheduled to represent the company during this event. With over 5,000 employees, including around 2,900 clinicians, Option Care Health focuses on enhancing care standards for patients with both acute and chronic conditions across all 50 states.
Option Care Health (NASDAQ: OPCH) announced its first-quarter earnings report will be released on May 6, 2021, before market opening. The management team will host a conference call at 8:30 a.m. E.T. to discuss the results. Option Care Health is the largest independent provider of home and alternate site infusion services in the U.S., employing over 5,000 individuals, including about 2,900 clinicians. The company aims to enhance care standards for patients with both acute and chronic conditions across all 50 states.
Option Care Health announced that an affiliate of Madison Dearborn Partners will sell 12,000,000 shares of its common stock at $20.00 per share in an underwritten public offering. This represents approximately 6.7% of shares outstanding, which may increase to 7.7% if the underwriter's option for an additional 1,800,000 shares is exercised. The sale is expected to close on March 17, 2021, with Goldman Sachs acting as the underwriter. Option Care will not receive any proceeds from this offering, and the Selling Stockholder's ownership will decrease from 54.0% to 47.3%.
Option Care Health announced the sale of 12 million shares of its common stock by Madison Dearborn Partners, representing approximately 6.7% of the total shares outstanding. The underwritten public offering includes a 30-day option for the underwriter to purchase an additional 1.8 million shares. After this sale, Madison Dearborn's ownership will decrease from 54% to 47.3%. The company will not receive any proceeds from this offering, and the sole underwriter is Goldman Sachs & Co. LLC.
Option Care Health (Nasdaq: OPCH) reported strong financial results for Q4 and full year 2020. Net revenue for Q4 reached $804.7 million, marking an 11.6% increase year-over-year. Full year net revenue was $3.032 billion, up 31.3%. The company achieved a net income of $17.8 million or $0.10 EPS, compared to a loss in the previous year. Adjusted EBITDA rose 69.5% to $221.7 million. Full year guidance for 2021 predicts revenue between $3.20 billion and $3.25 billion.
Option Care Health announced a public offering of 15,000,000 shares at $18.50 each, up from a previously planned 10,000,000 shares. The underwriter, Goldman Sachs, has a 30-day option to purchase an additional 2,250,000 shares. The offering will close on February 10, 2021. The sale will decrease the Selling Stockholder's interest in the Company from 63.6% to 55.2%. The Company will not receive any proceeds from this offering, which accounts for approximately 8.3% of the outstanding shares, or 9.6% with full exercise of the underwriter's option.
Option Care Health (NASDAQ: OPCH) announced the sale of 10,000,000 shares of its common stock by an affiliate of Madison Dearborn Partners in an underwritten public offering. This sale represents approximately 5.6% of shares outstanding and could increase to 6.4% with an additional 1,500,000 shares option. Post-offering, the Selling Stockholder's ownership will reduce from 63.6% to 58.0%. The offering is managed by Goldman Sachs & Co. LLC, and the Company will not receive any proceeds from the sale.
Option Care Health (NASDAQ: OPCH) announced preliminary financial results for Q4 and the fiscal year ending December 31, 2020. For Q4, net revenue is expected to be between $800 million to $805 million, an 11% growth year-over-year. Net income is projected at $16 million to $18 million, with adjusted EBITDA between $66 million to $68 million, reflecting a 25% to 28% increase. For FY 2020, net revenue is projected at approximately $3.03 billion, but a net loss is anticipated between $7.9 million to $9.9 million.
Option Care Health (NASDAQ: OPCH) has successfully issued $250 million in additional first lien term loans, aimed at extinguishing $246 million of second lien notes. This financing simplifies the company's capital structure and reduces its cash interest burden, as the interest rate on the new loans is set at Libor plus 3.75%, compared to Libor plus 8.75% for the extinguished notes. The new loans have a maturity date set for August 2026 and will reflect in the first quarter 2021 financial results.
Option Care Health (NASDAQ: OPCH) collaborates with Amedisys to deliver COVID antibody infusion therapy in long-term care facilities. This initiative follows FDA Emergency Use Authorizations for treatments by Eli Lilly and Regeneron. The pilot will begin in Indianapolis and Valparaiso, Indiana, leveraging both companies' clinical resources to serve this vulnerable population effectively. Amedisys will provide on-site care coordination, while Option Care Health will manage the pharmacy operations, ensuring efficient access to critical therapies for COVID-19 positive patients.